The efficacy and safety of anti-PD-1 antibody toripalimab combined with surufatinib in neoadjuvant treatment of locally advanced thyroid cancer: A phase II study.

被引：0
|
作者：
Chen, Jiaying
Ji, Qinghai
Wang, Yu
Huang, Naisi
Hu, Jiaqian
Wei, Wenjun
Huang, Caiping
Shen, Qiang
Li, Duanshu
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Dept Head & Neck Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6084
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Efficacy and prognosis biomarker of locally advanced ESCC patients treated with neoadjuvant chemotherapy and anti-PD-1 immunotherapy
    Li, Shuman
    Zhou, Jie
    Wang, Qianli
    Chen, Jiewei
    Qi, Yapeng
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [32] Safety and efficacy of AK112, an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors in a phase I dose escalation study.
    Coward, Jermaine
    Mislang, Anna Rachelle Austria
    Frentzas, Sophia
    Lemech, Charlotte Rose
    Nagrial, Adnan
    Jin, Xiaoping
    Li, Baiyong
    Wang, Zhongmin Maxwell
    Kwek, Kon Yew
    Xia, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with metastatic urothelial carcinoma: Preliminary results of an open-label phase II clinical study.
    Sheng, Xinan
    Chen, Haige
    Yao, Xin
    Hu, Yi
    Yao, Xudong
    Liu, Ziling
    Zhou, Fangjian
    Huang, Yiran
    Guo, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Efficacy and safety of camrelizumab combined with oxaliplatin and S-1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single-arm study
    Zhong, Wen-Jin
    Lin, Jian-An
    Wu, Chu-Ying
    Wang, Jiantian
    Chen, Jun-Xing
    Zheng, Huida
    Ye, Kai
    CANCER MEDICINE, 2024, 13 (03):
  • [35] Phase 2 Trial of Nivolumab, an Anti-PD-1 Monoclonal Antibody, as a Novel Neoadjuvant Pre-surgical Therapy for Locally Advanced Oral Cavity Cancer
    Kaczmar, J.
    Kompelli, A.
    Graboyes, E.
    Hornig, J.
    Lentsch, E.
    Day, T.
    Paulos, C.
    Young, M. R.
    Neskey, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1315 - 1315
  • [36] Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis
    Yuegang Li
    Yuwei Du
    Chi Xue
    Pei Wu
    Nan Du
    Guolian Zhu
    Huimian Xu
    Zhi Zhu
    BMC Gastroenterology, 22
  • [37] The Sequence of Chemotherapy and Toripalimab Might Influence the Efficacy of Neoadjuvant Chemoimmunotherapy in Locally Advanced Esophageal Squamous Cell Cancer-A Phase II Study
    Xing, Wenqun
    Zhao, Lingdi
    Zheng, Yan
    Liu, Baoxing
    Liu, Xianben
    Li, Tiepeng
    Zhang, Yong
    Ma, Baozhen
    Yang, Yonghao
    Shang, Yiman
    Fu, Xiaomin
    Liang, Guanghui
    Yuan, Dongfeng
    Qu, Jinrong
    Chai, Xiaofei
    Zhang, He
    Wang, Zibing
    Lin, Hongwei
    Liu, Liang
    Ren, Xiubao
    Zhang, Jiangong
    Gao, Quanli
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] Efficacy and safety of anti-PD-1/PD-L1 therapy in the treatment of advanced colorectal cancer: a meta-analysis
    Li, Yuegang
    Du, Yuwei
    Xue, Chi
    Wu, Pei
    Du, Nan
    Zhu, Guolian
    Xu, Huimian
    Zhu, Zhi
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [39] The efficacy and safety of neoadjuvant treatment with the PD-1 inhibitor for locally advanced colorectal cancer: a meta-analysis
    Yu, Yan
    Huang, Lin
    Yan, Rong
    Jiang, Min
    Li, Shuang-Jiao
    Fan, Wang-Dong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
    Mehnert, Janice M.
    Varga, Andrea
    Brose, Marcia S.
    Aggarwal, Rahul R.
    Lin, Chia-Chi
    Prawira, Amy
    de Braud, Filippo
    Tamura, Kenji
    Doi, Toshihiko
    Piha-Paul, Sarina A.
    Gilbert, Jill
    Saraf, Sanatan
    Thanigaimani, Pradeep
    Cheng, Jonathan D.
    Keam, Bhumsuk
    BMC CANCER, 2019, 19 (1)
12345